CFO of Deciphera Pharmaceuticals Inc (30-Year Financial, Insider Trades) Thomas Patrick Kelly (insider trades) sold 12,000 shares of DCPH on 01/03/2020 at an average price of $57.65 a share. The total sale was $691,800.
Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients. Deciphera Pharmaceuticals Inc has a market cap of $2.93 billion; its shares were traded at around $57.35 with and P/S ratio of 87.70.
CFO Recent Trades:
- CFO Thomas Patrick Kelly sold 12,000 shares of DCPH stock on 01/03/2020 at the average price of $57.65. The price of the stock has decreased by 0.52% since.
- CFO Thomas Patrick Kelly sold 40,000 shares of DCPH stock on 12/23/2019 at the average price of $68.21. The price of the stock has decreased by 15.92% since.
Directors and Officers Recent Trades:
- Director Michael Douglas Taylor sold 125,000 shares of DCPH stock on 01/03/2020 at the average price of $57.71. The price of the stock has decreased by 0.62% since.
- Director James Arthur Bristol sold 23,542 shares of DCPH stock on 01/03/2020 at the average price of $57.67. The price of the stock has decreased by 0.55% since.
- Chief Business Officer Christopher John Morl sold 16,137 shares of DCPH stock on 01/02/2020 at the average price of $58.55. The price of the stock has decreased by 2.05% since.
- Chief Business Officer Christopher John Morl sold 15,034 shares of DCPH stock on 12/12/2019 at the average price of $60. The price of the stock has decreased by 4.42% since.
- Chief Scientific Officer Daniel Lee Flynn sold 31,029 shares of DCPH stock on 12/12/2019 at the average price of $60. The price of the stock has decreased by 4.42% since.
For the complete insider trading history of DCPH, click here
.
